Phase 2 Study of DS-8500a in Patients With Type 2 Diabetes

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT02222350

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02222350
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02222350. Randomized; quadruple masking; primary purpose treatment. Start 2014-07 (registry gives no type); primary completion 2014-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Phase 2 Study of DS-8500a in Patients With Type 2 Diabetes
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
10mg DS-8500a tablet
Intervention (Drug)
75mg DS-8500a tablet
Intervention (Drug)
placebo
Lead sponsor
Daiichi Sankyo Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct02222350
Content hash
e5e1e3b306fec5784e790148571427362266527288089d569721f3f040df7850